Company: BIVIW
Filing Date: 2025-05-15
Form Type: DRS
Source: 0001520138-25-000149
Chunk: 61

Company: BIOVIE INC.
Filing Date: 2025-05-15
Form: DRS
Chunk 61
---
.

We will furnish without charge to each person,
including any beneficial owner, to whom a prospectus is delivered, upon written or oral request, a copy of any or all of the documents
incorporated by reference into this prospectus but not delivered with this prospectus, including exhibits that are specifically incorporated
by reference into such documents. You should direct any requests for documents to BioVie Inc., Attention: Corporate Secretary, 680 W Nye
Lane, Suite 201, Carson City, Nevada 89703. Our phone number is (775) 888-3162.

You may also access these documents, free of charge
on the SEC’s website at www.sec.gov or on our website at https://bioviepharma.com. Information contained on our website is
not incorporated by reference into this prospectus, and you should not consider any information on, or that can be accessed from, our
website as part of this prospectus or any accompanying prospectus supplement.

You should rely only on information contained
in, or incorporated by reference into, this prospectus and any prospectus supplement. We have not authorized anyone to provide you with
information different from that contained in this prospectus or incorporated by reference into this prospectus. We are not making offers
to sell the securities in any jurisdiction in which such an offer or solicitation is not authorized or in which the person making such
offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make such offer or solicitation.

<div align='center'>39

Units, Each Consisting of One Share of Class A Common Stock and One Warrant to Purchase One Share of Class A Common Stock

Pre-Funded Units, Each Consisting of One Pre-Funded Warrant to Purchase One Share of Class A Common Stock and One Warrant to Purchase One Share of Class A Common Stock

Shares of Class A Common Stock Underlying the Warrants

Shares of Class A Common Stock Underlying the Pre-Funded Warrants

BioVie Inc.</div>

| PRELIMINARY PROSPECTUS |

<div align='center'>ThinkEquity

, 2025

Part II

Information not required in prospectus</div>

Item 13. Other Expenses of Issuance and Distribution

The following table sets forth various expenses
being borne by the Company in connection with the sale and distribution of the securities being registered. All of the amounts shown are
estimates except for the Securities and Exchange Commission Registration Fee